Our September Survey: Pop Watch
Pop culture and mainstream media have the ability to influence the masses through the stories and information they relay. They can help educate and dispel myths about HIV/AIDS, but they can also reinforce negative stereotypes.
Do you feel that you and your concerns about HIV/AIDS are adequately portrayed in pop culture?
In general, how would you rate mainstream media’s recent coverage on HIV/AIDS? Let us know.

Our September Survey: Pop Watch

Pop culture and mainstream media have the ability to influence the masses through the stories and information they relay. They can help educate and dispel myths about HIV/AIDS, but they can also reinforce negative stereotypes.

Do you feel that you and your concerns about HIV/AIDS are adequately portrayed in pop culture?

In general, how would you rate mainstream media’s recent coverage on HIV/AIDS? Let us know.

ViiV’s New HIV Drug “Trii” Has Officially Been FDA-Approved
Triumeq is a tablet that must be taken daily. Each tablet contains 50 mg dolutegravir, 600 mg abacavir, and 300 mg lamivudine. The correct dose is one pill taken once daily, either with or without food.
FDA approval is based on data from two clinical trials: In one trial involving people starting ARV therapy for the first time, the regimen was found to be superior to Atripla. Another study confirmed that taking Triumeq results in blood levels of the ARVs equivalent to all 3 drugs taken together as separate tablets.
It is not recommended for people with known HIV resistance to abacavir, lamivudine, or any of the approved intergrase inhibitors.
Click here for a complete guide to the latest fixed-dose, once-daily combination tablet, Triumeq.

ViiV’s New HIV Drug “Trii” Has Officially Been FDA-Approved

  • Triumeq is a tablet that must be taken daily. Each tablet contains 50 mg dolutegravir, 600 mg abacavir, and 300 mg lamivudine. The correct dose is one pill taken once daily, either with or without food.
  • FDA approval is based on data from two clinical trials: In one trial involving people starting ARV therapy for the first time, the regimen was found to be superior to Atripla. Another study confirmed that taking Triumeq results in blood levels of the ARVs equivalent to all 3 drugs taken together as separate tablets.
  • It is not recommended for people with known HIV resistance to abacavir, lamivudine, or any of the approved intergrase inhibitors.


Click here for a complete guide to the latest fixed-dose, once-daily combination tablet, Triumeq.

POZ Q&A: Meet The Jeug’e MasterCelebrity glamour technician Karim Odoms took time from his Paris workload to answer POZ’s questions about his career—and why he’s so outspoken about HIV/AIDS.
"I’ve learned to respect that everyone cannot handle dating someone with HIV, and that is OK. However, I find it funny when you meet guys who say, “It’s cool, no problem,” and then you never hear from them ever again—until you run into them at the AIDS Walk, and they’re like, “Oh I’m here supporting my friend.” *blank stare* LOL."

POZ Q&A: Meet The Jeug’e Master

Celebrity glamour technician Karim Odoms took time from his Paris workload to answer POZ’s questions about his career—and why he’s so outspoken about HIV/AIDS.

"I’ve learned to respect that everyone cannot handle dating someone with HIV, and that is OK. However, I find it funny when you meet guys who say, “It’s cool, no problem,” and then you never hear from them ever again—until you run into them at the AIDS Walk, and they’re like, “Oh I’m here supporting my friend.” *blank stare* LOL."